David Marek compensation by year
Myovant Sciences Summary Compensation Table · all 2 fiscal years held| Component | FY2020 | FY2021 |
|---|---|---|
| Salary | $150,544 | $750,000 |
| Bonus | $1,000,000 | $0 |
| Stock awards | $4,581,981 | $2,410,027 |
| Option awards | $4,383,438 | $2,407,333 |
| Non-equity incentive | $116,000 | $473,000 |
| Pension and deferred compensation | $0 | $0 |
| All other | $44,554 | $207,149 |
| Total | $10,276,517 | $6,247,509 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Myovant Sciences Ltd. DEF 14A filed July 28, 2022, accession 0001140361-22-027161, and prior-year filings.
How this page was built: the Myovant Sciences Ltd. filed document, accession 0001140361-22-027161. Every figure is read from that document and cited to the page and table it appears in. Filed July 28, 2022.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 167,307 | $2,228,529 | — |
| RSU | 134,789 | $1,795,389 | — |
| Option | 229,821 | — | $20.54 |
| Option | 208,218 | — | $17.88 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Myovant Sciences Ltd.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Myovant Sciences’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| David Marek · this page | Principal Executive Officer | $6,247,509 |
| Uneek Mehra | Principal Financial Officer | $5,164,872 |
| Frank Karbe | Former Principal Financial and Accounting Officer | $4,451,137 |
| Lauren Merendino | Chief Commercial Officer | $3,463,677 |
Board service
Myovant Sciences board · FY2022How this board is paid
Company policy: Myovant Sciences pays directors a $50,000 cash retainer and $266,200 in Options. As stated in Myovant Sciences's FY2022 proxy.
The full Myovant Sciences compensation record
free company briefThis page is one person within Myovant Sciences's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Myovant Sciences proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Myovant Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.